InvestLog
ANVS logo

ANVS

Annovis Bio, Inc.NYSEHealthcare
$2.35+3.07%ClosedMarket Cap: $46.2M

As of 2026-04-07

Analyst Consensus

Consensus

Buy

Target (Consensus)

$25.67

Target (Median)

$26.00

Target Range

$21.00 - $30.00

Upside from current price: 992.3%

Rating Distribution

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-09-30Canaccord GenuitymaintainBuyBuy
2025-09-03HC Wainwright & Co.maintainBuyBuy
2025-06-09HC Wainwright & Co.maintainBuyBuy
2025-05-15Canaccord GenuitymaintainBuyBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.18$16.7M1
Sun Dec 31$-1.61$50.5M2
Mon Dec 31$-0.40$208.7M1
Tue Dec 31$1.70$385.0M1